AA

Areeb Abdulla Ansari

Active Director Director DIN 11528640
DIN 11528640 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Areeb Abdulla Ansari

Data last updated:

Areeb Abdulla Ansari is a Director at Linden Pharma Limited (since 2026) and Director at Unitrade International Private Limited (since 2026).

DIN 11528640
Primary Designation Director
First Appointment 06 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Linden Pharma Limited U46497TS2026PLC217793
Director17 Jun 20262026Active
Director06 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Unitrade International Private Limited
Linden Pharma Limited
Premium access

Shareholding and investment profile for Areeb Abdulla Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Areeb Abdulla Ansari

Areeb Abdulla Ansari currently holds 2 directorships: Linden Pharma Limited (Director, since 17 Jun 2026); Unitrade International Private Limited (Director, since 06 Feb 2026).

Areeb Abdulla Ansari was first appointed on 06 Feb 2026 as Director at Unitrade International Private Limited.

The current boards of Areeb Abdulla Ansari's companies include Abdulla Abdul Aziz Ansari (Linden Pharma Limited), Aqueeluddin Ahmed Syed (Linden Pharma Limited), Mohd Sajeed Iqubal Ansari Mohd Naseeruddin Ansari (Linden Pharma Limited), Salim Ahmad Abdul Aziz Ansari (Linden Pharma Limited), Shaik Abdul Hameed (Linden Pharma Limited), Zaid Salim Ansari (Linden Pharma Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available